Low Myo-inositol indicating astrocytic damage in a case series of neuromyelitis optica

Annals of Neurology

Volumn 74, Issue 2, 2013, Pages 301-305

  Ciccarelli, Olga ^a,b   Thomas, David L ^a   De Vita, Enrico ^a,c   Wheeler Kingshott, Claudia A M ^a   Kachramanoglou, Carolina ^a   Kapoor, Raj ^b,c   Leary, Siobhan ^c   Matthews, Lucy ^d   Palace, Jacqueline ^d   Chard, Declan ^a,b   Miller, David H ^a,b   Toosy, Ahmed T ^a   Thompson, Alan J ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETA1A INTERFERON; CORTICOSTEROID; CREATINE; INOSITOL; MITOXANTRONE; N ACETYLASPARTIC ACID; PREDNISOLONE; STEROID;

ADULT; ARTICLE; ASTROCYTE; CELL DAMAGE; CERVICAL SPINAL CORD INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FORAMEN MAGNUM; GUILLAIN BARRE SYNDROME; HICCUP; HUMAN; IN VIVO STUDY; LIMB WEAKNESS; LOW BACK PAIN; MALE; MONOPLEGIA; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PARESTHESIA; PLASMAPHERESIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUADRIPLEGIA; URINARY URGENCY;

ADULT; ASTROCYTES; BIOLOGICAL MARKERS; CERVICAL VERTEBRAE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INOSITOL; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; SPINAL CORD;

EID: 84884909846     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.23909     Document Type: Article

References (13)

1. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol 2007; 6: 805-815.
2. Kinoshita M, Nakatsuji Y, Moriya M, et al. Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum. Neuroreport 2009; 20: 508-512.
3. Hinson SR, Romero MF, Popescu BF, et al. Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes. Proc Natl Acad Sci U S A 2012; 109: 1245-1250.
4. Ciccarelli O, Wheeler-Kingshott CA, McLean MA, et al. Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis. Brain 2007; 130: 2220-2231.
5. Sajja BR, Wolinsky JS, Narayana PA,. Proton magnetic resonance spectroscopy in multiple sclerosis. Neuroimaging Clin N Am 2009; 19: 45-58.
6. Marignier R, Nicolle A, Watrin C, et al. Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury. Brain 2010; 133: 2578-2591.
7. Takano R, Misu T, Takahashi T, et al. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study. Neurology 2010; 75: 208-216.
8. Marliani AF, Clementi V, Albini RL, et al. Quantitative cervical spinal cord 3T proton MR spectroscopy in multiple sclerosis. AJNR Am J Neuroradiol 2010; 31: 180-184.
9. Bjartmar C, Kidd G, Mork S, et al. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 2000; 48: 893-901.
10. Bates TE, Strangward M, Keelan J, et al. Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. Neuroreport 1996; 7: 1397-1400.
11. De SJ, Blanc F, Kremer S, et al. Magnetic resonance spectroscopy evaluation in patients with neuromyelitis optica. J Neurol Neurosurg Psychiatry 2010; 81: 409-411.
12. Pichiecchio A, Tavazzi E, Poloni G, et al. Advanced magnetic resonance imaging of neuromyelitis optica: a multiparametric approach. Mult Scler 2012; 18: 817-824.
13. Narayana PA, Doyle TJ, Lai D, et al. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann Neurol 1998; 43: 56-71.